Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-04-25-Speech-3-189"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2007-04-25"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20070425.32.3-189"2
lpv:hasSubsequent	lp_eu:2007-04-25-Speech-3-1902
lpv:speaker	lp:Hiltrud Breyer2
lpv:spokenAs	member; G/EFA (2004-07-20--2009-07-13)3 member; FEMM (2007-01-31--2009-07-13)3 substitute; JURI (2007-01-31--2009-07-13)3 member; ENVI (2007-01-31--2009-07-13)3 member; Delegation for relations with Japan (2007-03-14--2009-07-13)3 unknown; Bündnis 90/Die Grünen (2004-07-20--2009-07-13)3
lpv:translated text	". By giving the green light for the legally-vague regulation of new therapies, the majority of this House has allowed itself to be blinded by an alliance of social democrats, the Commission and the German Government, and in doing so has sold its own values. It is shameful that Members should wipe from the board the explicit ban on the commercialisation of the human body, on interference with genetic identity and on the production of human-animal hybrids. The vote was influenced to an enormous degree by intensive lobbying on behalf of the German Government, which, while presiding over the Council, helped to bring about the demolition of the European values highlighted in the Berlin Declaration and to ensure that they were paid no more than lip-service. Only the proposal by Parliament’s Committee on Legal Affairs (on which I was the rapporteur) for the removal of human embryo stem cells from the scope of the regulation would have assured legal clarity and security. It is now more than a matter of suspicion that representatives of the German Government wanted to use the European Union to nullify German legislation on stem cells, and the Commission’s derogation, which this House now supports in principle, will not stand up in a court of law. Parliament has today failed to go as far as the prevailing European consensus, expressed in the EU’s Charter of Fundamental Rights and in the directive on biotechnology patents, and has opened the door to people being treated as commercial goods. We can still hope that other Member States on the Council will be courageous enough to stop the slide in bioethics heralded today and call for a complete turnaround."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph